Jennison Associates LLC Takes Position in Sanofi (NASDAQ:SNY)

Jennison Associates LLC bought a new stake in shares of Sanofi (NASDAQ:SNY) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 159,507 shares of the company’s stock, valued at approximately $7,932,000.

Other large investors have also recently made changes to their positions in the company. Clearbridge Investments LLC increased its position in shares of Sanofi by 8.4% during the 3rd quarter. Clearbridge Investments LLC now owns 184,630 shares of the company’s stock valued at $9,904,000 after purchasing an additional 14,362 shares during the last quarter. Dynamic Advisor Solutions LLC bought a new position in shares of Sanofi during the 4th quarter worth $2,104,000. Soros Fund Management LLC bought a new position in shares of Sanofi during the 3rd quarter worth $11,533,000. International Assets Investment Management LLC bought a new position in shares of Sanofi during the 4th quarter worth $4,704,000. Finally, Clear Street Markets LLC grew its stake in shares of Sanofi by 352.8% during the 3rd quarter. Clear Street Markets LLC now owns 130,183 shares of the company’s stock worth $6,983,000 after acquiring an additional 101,430 shares during the period. 10.04% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

SNY has been the subject of several research reports. StockNews.com downgraded Sanofi from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, February 27th. Morgan Stanley initiated coverage on Sanofi in a research note on Tuesday, January 23rd. They set an “equal weight” rating and a $55.00 price target for the company. Finally, TheStreet downgraded Sanofi from a “b” rating to a “c” rating in a research note on Friday, February 9th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $55.00.

Sanofi Stock Down 0.5 %

Shares of NASDAQ SNY opened at $49.13 on Friday. Sanofi has a 52 week low of $42.63 and a 52 week high of $56.26. The business has a 50-day simple moving average of $47.71 and a two-hundred day simple moving average of $48.41. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.19. The company has a market cap of $124.28 billion, a P/E ratio of 24.69, a P/E/G ratio of 1.49 and a beta of 0.61.

Sanofi (NASDAQ:SNY) last issued its earnings results on Thursday, February 1st. The company reported $0.89 EPS for the quarter, missing the consensus estimate of $0.94 by ($0.05). Sanofi had a return on equity of 19.69% and a net margin of 10.52%. The company had revenue of $11.76 billion during the quarter, compared to the consensus estimate of $13.02 billion. Research analysts anticipate that Sanofi will post 4.09 earnings per share for the current fiscal year.

Sanofi Increases Dividend

The firm also recently declared an annual dividend, which will be paid on Thursday, June 6th. Stockholders of record on Friday, May 10th will be given a dividend of $1.478 per share. This represents a dividend yield of 2.98%. The ex-dividend date of this dividend is Thursday, May 9th. This is an increase from Sanofi’s previous annual dividend of $1.38. Sanofi’s dividend payout ratio (DPR) is 69.35%.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.